{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:22:55Z","timestamp":1790281375395,"version":"4.1.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1093\/carcin\/bgq211","type":"journal-article","created":{"date-parts":[[2010,10,18]],"date-time":"2010-10-18T21:15:06Z","timestamp":1287436506000},"page":"10-18","source":"Crossref","is-referenced-by-count":22,"title":["p57 Kip2 is a downstream effector of BCR\u2013ABL kinase inhibitors in chronic myelogenous leukemia cells"],"prefix":"10.1093","volume":"32","author":[{"given":"Adriana","family":"Borriello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Caldarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Bencivenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Cucciolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Usala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Danise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Ronzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silverio","family":"Perrotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvio","family":"Della Ragione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,10,15]]},"reference":[{"key":"key\n\t\t\t\t20170520225240_bib1","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","article-title":"The molecular biology of chronic myeloid leukemia","volume":"96","author":"Deininger","year":"2000","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170520225240_bib2","first-page":"2343","article-title":"The BCR gene and Philadelphia chromosome-positive leukemogenesis","volume":"61","author":"Laurent","year":"2001","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170520225240_bib3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s002770050473","article-title":"Molecular pathogenesis of chronic myeloid leukemia: implications for new therapeutic strategies","volume":"78","author":"Warmuth","year":"1999","journal-title":"Ann. Hematol."},{"key":"key\n\t\t\t\t20170520225240_bib4","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1172\/JCI115985","article-title":"Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV","volume":"90","author":"Verfaillie","year":"1992","journal-title":"J. Clin. Invest."},{"key":"key\n\t\t\t\t20170520225240_bib5","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0022-2143(97)90192-X","article-title":"Pathophysiology of CML: do defects in integrin function contribute to the premature circulation and massive expansion of the BCR\/ABL positive clone?","volume":"129","author":"Verfaillie","year":"1997","journal-title":"J. Lab. Clin. Med."},{"key":"key\n\t\t\t\t20170520225240_bib6","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood.V83.8.2038.2038","article-title":"Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia","volume":"83","author":"Bedi","year":"1994","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170520225240_bib7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/ng791","article-title":"BCR-ABL suppresses C\/EBPa expression through inhibitory action of hnRNP E2","volume":"30","author":"Pernotti","year":"2002","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170520225240_bib8","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1182\/blood.V96.6.2246","article-title":"CGP57148B (STI-571) induces differentiation and apoptosis and sensitizes Bcr-Abl-positive human leukemia cells to apoptosis due to antileukemic drugs","volume":"96","author":"Fang","year":"2000","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170520225240_bib9","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1126\/science.2406902","article-title":"Induction of chronic myelogenous leukemia in mice by the P210bcr\/abl gene of the Philadelphia chromosome","volume":"247","author":"Daley","year":"1990","journal-title":"Science"},{"key":"key\n\t\t\t\t20170520225240_bib10","first-page":"796","article-title":"BCR\/ABL confers growth factor independence upon a murine myeloid cell line","volume":"6","author":"Mandanas","year":"1992","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20170520225240_bib11","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1093\/emboj\/16.20.6151","article-title":"Transformation of hematopoietic cells by BCR\/ABL requires activation of a PI-3k\/Akt-dependent pathway","volume":"16","author":"Skorski","year":"1997","journal-title":"EMBO J."},{"key":"key\n\t\t\t\t20170520225240_bib12","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/j.1460-2075.1994.tb06319.x","article-title":"Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway","volume":"13","author":"Puil","year":"1994","journal-title":"EMBO J."},{"key":"key\n\t\t\t\t20170520225240_bib13","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1084\/jem.191.6.977","article-title":"Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL","volume":"191","author":"Horita","year":"2000","journal-title":"J. Exp. Med."},{"key":"key\n\t\t\t\t20170520225240_bib14","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Druker","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"key\n\t\t\t\t20170520225240_bib15","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra013339","article-title":"Imatinib mesylate\u2014a new oral targeted therapy","volume":"346","author":"Savane","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"key\n\t\t\t\t20170520225240_bib16","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM200104053441402","article-title":"Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome","volume":"344","author":"Druker","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"key\n\t\t\t\t20170520225240_bib17","doi-asserted-by":"crossref","first-page":"39223","DOI":"10.1074\/jbc.M007291200","article-title":"BCR\/ABL regulates expression of the cyclin dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-kinase\/AKT pathway","volume":"275","author":"Gesbert","year":"2000","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170520225240_bib18","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1182\/blood.V96.5.1933","article-title":"Bcr-Abl kinase down-regulates cyclin-dependent kinase inhibitor p27 in human and murine cell lines","volume":"96","author":"Jonuleit","year":"2000","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170520225240_bib19","doi-asserted-by":"crossref","first-page":"10538","DOI":"10.1073\/pnas.190104497","article-title":"Abnormal integrin mediated regulation of chronic myelogenous leukemia CD34+ cell proliferation: BCR\/ABL up-regulates the cyclin-dependent kinase inhibitor, p27Kip, which is relocated to the cell cytoplasm and incapable of regulating cdk2 activity","volume":"97","author":"Jiang","year":"2000","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"key\n\t\t\t\t20170520225240_bib20","doi-asserted-by":"crossref","first-page":"23572","DOI":"10.1074\/jbc.M101885200","article-title":"BCR-ABL and interleukin 3 promote haematopoietic cell proliferation and survival through modulation of cyclin D2 and p27Kip1 expression","volume":"276","author":"Parada","year":"2001","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170520225240_bib21","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1158\/0008-5472.CAN-04-1357","article-title":"BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27 Kip1 degradation and proliferation of chronic myelogenous leukemia cells","volume":"65","author":"Andreu","year":"2005","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170520225240_bib22","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1038\/sj.leu.2404842","article-title":"Pleiotropic p27Kip1, BCR-ABL and leukemic stem cell: the trio in concert","volume":"21","author":"Sengupta","year":"2007","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20170520225240_bib23","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1182\/blood-2007-09-113860","article-title":"Absence of SKP2 expression attenuates BCR-ABL\u2013induced myeloproliferative disease","volume":"112","author":"Agarwal","year":"2008","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170520225240_bib24","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V114.22.3276.3276","article-title":"The oncogenic role of tumor suppressor protein p27 in Ph+ chronic myeloid leukemia","volume":"114","author":"Agarwal","year":"2009","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170520225240_bib25","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/nrc1501","article-title":"Regulation of the cytoskeleton: an oncogenic function for CDK inhibitors","volume":"4","author":"Besson","year":"2004","journal-title":"Nat. Rev. Cancer."},{"key":"key\n\t\t\t\t20170520225240_bib26","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.4161\/cc.6.9.4142","article-title":"p27Kip1 metabolism: a fascinating labyrinth","volume":"6","author":"Borriello","year":"2007","journal-title":"Cell Cycle"},{"key":"key\n\t\t\t\t20170520225240_bib27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.devcel.2008.01.013","article-title":"CDK inhibitors: cell cycle regulators and beyond","volume":"14","author":"Besson","year":"2008","journal-title":"Dev. Cell."},{"key":"key\n\t\t\t\t20170520225240_bib28","doi-asserted-by":"crossref","first-page":"5192","DOI":"10.1073\/pnas.0811712106","article-title":"Common and specific roles of the related CDK inhibitors p27 and p57 revealed by a knock-in mouse model","volume":"106","author":"Susaki","year":"2009","journal-title":"Proc. Natl Acad. USA."},{"key":"key\n\t\t\t\t20170520225240_bib29","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1158\/1541-7786.MCR-09-0317","article-title":"p57KIP2: \u201cKip\u201ding the cell under control","volume":"7","author":"Pateras","year":"2009","journal-title":"Mol. Cancer Res."},{"key":"key\n\t\t\t\t20170520225240_bib30","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/carcin\/bgn010","article-title":"Histone deacetylase inhibitors upregulate p57Kip2 level by enhancing its expression through Sp1 transcription factor","volume":"29","author":"Cucciolla","year":"2008","journal-title":"Carcinogenesis"},{"key":"key\n\t\t\t\t20170520225240_bib31","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1096\/fj.07-101394","article-title":"Imatinib mesylate-resistant human chronic myelogenous leukemia cell lines exhibit high sensitivity to the phytoalexin resveratrol","volume":"22","author":"Puissant","year":"2008","journal-title":"FASEB J."},{"key":"key\n\t\t\t\t20170520225240_bib32","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bcmd.2007.07.006","article-title":"Erythroid differentiation and maturation from peripheral CD34+ cells in liquid culture: cellular and molecular characterization","volume":"40","author":"Ronzoni","year":"2008","journal-title":"Blood Cells Mol. Dis."},{"key":"key\n\t\t\t\t20170520225240_bib33","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1158\/0008-5472.CAN-05-2759","article-title":"Retinoic acid induces p27 Kip1 nuclear accumulation by modulatine its phosphorylation","volume":"66","author":"Borriello","year":"2006","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170520225240_bib34","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1182\/blood-2006-11-057521","article-title":"Nilotinib exerts equipotent antiproliferative effects to imatinib and does not induce apoptosis in CD34 + CML cells","volume":"109","author":"J\u00f8rgensen","year":"2007","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170520225240_bib35","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1349-7006.2003.tb01482.x","article-title":"Reversal of the resistance to STI571 in human chronic myelogenous leukemia K562 cells","volume":"94","author":"Mukai","year":"2003","journal-title":"Cancer Sci."},{"key":"key\n\t\t\t\t20170520225240_bib36","doi-asserted-by":"crossref","first-page":"10231","DOI":"10.1073\/pnas.1831009100","article-title":"Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation","volume":"100","author":"Kamura","year":"2003","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"key\n\t\t\t\t20170520225240_bib37","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.4049\/jimmunol.173.4.2383","article-title":"Identification of multiple cell cycle regulatory functions of p57 Kip2 in human T lymphocytes","volume":"173","author":"Li","year":"2004","journal-title":"J. Immunol."},{"key":"key\n\t\t\t\t20170520225240_bib38","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0002-9440(10)64605-6","article-title":"Expression of p57(KIP2) potently blocks the growth of human astrocytomas and induces cell senescence","volume":"157","author":"Tsugu","year":"2000","journal-title":"Am. J. Pathol."},{"key":"key\n\t\t\t\t20170520225240_bib39","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.1128\/MCB.01743-05","article-title":"E Proteins and Id2 converge on p57Kip2 to regulate cell cycle in neural cells","volume":"26","author":"Rothschild","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"key\n\t\t\t\t20170520225240_bib40","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bbrc.2005.09.008","article-title":"p57Kip2 is expressed in quiescent mouse bone marrow side population cells","volume":"337","author":"Umemoto","year":"2005","journal-title":"Biochem. Biophys. Res Commun."},{"key":"key\n\t\t\t\t20170520225240_bib41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/387151a0","article-title":"Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome","volume":"387","author":"Zhang","year":"1997","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170520225240_bib42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1101\/gad.13.2.213","article-title":"p21(CIP1) and p57(KIP2) control muscle differentiation at the myogenin step","volume":"13","author":"Zhang","year":"1999","journal-title":"Genes Dev."},{"key":"key\n\t\t\t\t20170520225240_bib43","doi-asserted-by":"crossref","first-page":"12197","DOI":"10.1074\/jbc.274.18.12197","article-title":"p57(Kip2) is degraded through the proteasome in osteoblasts stimulated to proliferation by transforming growth factor beta1","volume":"274","author":"Urano","year":"1999","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170520225240_bib44","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0925-4773(99)00106-9","article-title":"Spatial and temporal expression of p57(KIP2) during murine lens development","volume":"86","author":"Lovicu","year":"1999","journal-title":"Mech. Dev."},{"key":"key\n\t\t\t\t20170520225240_bib45","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1365-2141.1995.tb05358.x","article-title":"Involvement of the cyclin-dependent kinase-4 inhibitor (CDKN2) gene in the pathogenesis of lymphoid blast crisis of chronic myelogenous leucemia","volume":"91","author":"Serra","year":"1995","journal-title":"Br. J. Haematol."},{"key":"key\n\t\t\t\t20170520225240_bib46","doi-asserted-by":"crossref","first-page":"e4482","DOI":"10.1371\/journal.pone.0004482","article-title":"Imprinted CDKN1C is a tumor suppressor in rhabdoid tumor and activated by restoration of SMARCB1 and histone deacetylase inhibitors","volume":"4","author":"Algar","year":"2009","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170520225240_bib47","doi-asserted-by":"crossref","first-page":"32272","DOI":"10.1074\/jbc.M602776200","article-title":"CTIP2 associates with the NuRD complex on the promoter of p57KIP2, a newly identified CTIP2 target gene","volume":"281","author":"Topark-Ngarm","year":"2006","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170520225240_bib48","doi-asserted-by":"crossref","first-page":"e5011","DOI":"10.1371\/journal.pone.0005011","article-title":"CDKN1C (p57KIP2) is adirect target of EZH2 and suppressed by multiple epigenetic mechanisms in breast cancer cells","volume":"4","author":"Yang","year":"2009","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170520225240_bib49","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1073\/pnas.062491899","article-title":"Induction of p57 (KIP2) expression by p73beta","volume":"99","author":"Blint","year":"2002","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"key\n\t\t\t\t20170520225240_bib50","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1038\/sj.onc.1210143","article-title":"Transcriptional upregulation of p57 (Kip2) by the cyclin dependent kinase inhibitor BMS-387032 is E2F dependent and serves as a negative feedback loop limiting cytotoxicity","volume":"26","author":"Ma","year":"2007","journal-title":"Oncogene"}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/32\/1\/10\/17288153\/bgq211.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T01:29:12Z","timestamp":1592011752000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article-lookup\/doi\/10.1093\/carcin\/bgq211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,15]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,10,15]]},"published-print":{"date-parts":[[2011,1]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgq211","relation":{},"ISSN":["1460-2180","0143-3334"],"issn-type":[{"value":"1460-2180","type":"electronic"},{"value":"0143-3334","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10,15]]}}}